For the quarter ending 2025-09-30, RLMD has $14,876,244 in assets. $5,410,705 in debts. $1,384,484 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,384,484 | 1,353,351 | ||
| Short-term investments | 12,502,040 | 19,266,190 | ||
| Prepaid expenses | 967,745 | 474,628 | ||
| Total current assets | 14,854,269 | 21,094,169 | ||
| Other assets | 21,975 | 21,975 | ||
| Total assets | 14,876,244 | 21,116,144 | ||
| Accounts payable | 1,453,102 | 1,361,911 | ||
| Accrued expenses | 3,736,496 | 3,772,636 | ||
| Total current liabilities | 5,189,598 | 5,134,547 | ||
| Preferred stock value-Preferred Class A | - | 0 | ||
| Stock appreciation rights | 221,107 | 32,116 | ||
| Preferred stock value | - | 0 | ||
| Total liabilities | 5,410,705 | 5,166,663 | ||
| Common stock, 0.001 par value, 150,000,000 shares authorized, 33,191,622 and 30,174,202 shares issued and outstanding, respectively | 33,191 | 33,191 | ||
| Additional paid-in capital | 687,831,786 | 684,224,232 | ||
| Accumulated deficit | -678,399,438 | -668,307,942 | ||
| Total stockholders equity | 9,465,539 | 15,949,481 | ||
| Total liabilities and stockholders equity | 14,876,244 | 21,116,144 | ||
RELMADA THERAPEUTICS, INC. (RLMD)
RELMADA THERAPEUTICS, INC. (RLMD)